TransEnterix Acquires A Second, Launch-Ready Surgical Robot System
This article was originally published in The Gray Sheet
Executive Summary
The firm acquired the robotics division of Sofar SPA for up to $99.8 million, including milestone payments, and will begin marketing Sofar's Telelap Alf-X robotic minimally invasive surgery system in international markets immediately. The system will complement TransEnterix's SurgiBot, which is pending a 510(k) decision.